Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China; Hunan Key Laboratory of Nonresolving Inflammation and Cancer, Changsha, Hunan, 410013, China.
Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
Biochem Biophys Res Commun. 2020 Aug 20;529(2):500-506. doi: 10.1016/j.bbrc.2020.04.049. Epub 2020 Jul 2.
Recently, the role of long non-coding RNAs (lncRNAs) in regulating multiple cancer types has attracted increasing interest because of their involvement in cell metastasis in different cancer types. Previous studies indicated that LINC00657 may work as an oncogene in gastric and colon cancer. However, the functional role and mechanistic action of LINC00657 on colorectal cancer (CRC) remains unknown. Therefore, in this study, the role of LINC00657 in CRC was evaluated. Our results showed that LINC00657 was enriched in CRC stem-like cells (CSCs) and significantly promoted CSCs invasion ability. LINC00657 expression resulted frequently up-regulated in CRC patient tissue, and high expression of LINC00657 was correlated with an advanced clinical stage, lymph node metastasis, distant metastasis and poor overall survival of CRC patients. Furthermore, LINC00657 worked as a competing endogenous RNA (ceRNA) for miR-203a, antagonizing its function as a tumor suppressor and leading to the de-repression of CSCs invasion. Collectively, our observations revealed that LINC00657 is involved in CRC invasion by acting as a competing endogenous RNA. Thus, LINC00657 may serve as a potential prognostic factor and/or therapeutic target for CRC.
最近,长链非编码 RNA(lncRNAs)在调节多种癌症类型中的作用引起了越来越多的关注,因为它们参与了不同癌症类型的细胞转移。先前的研究表明,LINC00657 可能在胃癌和结肠癌中作为癌基因发挥作用。然而,LINC00657 对结直肠癌(CRC)的功能作用和机制作用仍不清楚。因此,在本研究中评估了 LINC00657 在 CRC 中的作用。我们的结果表明,LINC00657 在 CRC 干细胞样细胞(CSCs)中富集,并显著促进 CSCs 的侵袭能力。LINC00657 的表达在 CRC 患者组织中经常上调,LINC00657 的高表达与 CRC 患者的晚期临床分期、淋巴结转移、远处转移和不良总生存率相关。此外,LINC00657 作为 miR-203a 的竞争性内源 RNA(ceRNA)发挥作用,拮抗其作为肿瘤抑制因子的功能,并导致 CSCs 侵袭的去抑制。总之,我们的观察结果表明,LINC00657 通过作为竞争性内源 RNA 参与 CRC 的侵袭。因此,LINC00657 可能作为 CRC 的潜在预后因子和/或治疗靶点。